Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

Bristol-Myers Squibb · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
non-small-cell lung carcinoma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834767
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.